Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atrophogenic Effect of Hydrocortison vs Pimecrolimus in Atopic Dermatitis
NCT00610142Phase 2Completed
- Sponsor
- Technische Universität Dresden
- Start
- Dec 2007
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of Pimecrolimus vehicle + topical corticosteroid in atopic dermatitis (AD) (2 arms), sponsored by Technische Universität Dresden. Primary endpoint: thickness of epidermis at 4 weeks. Started Dec 2007; status: completed.
02
Drugs
Pimecrolimus vehicle + topical corticosteroid
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT00610142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00610142.